Header Logo

Connection

SETH LERNER to BRCA2 Protein

Back to Details
This is a "connection" page, showing publications SETH LERNER has written about BRCA2 Protein.
SETH LERNER
Connection Strength
0.060
BRCA2 Protein
  1. Clinical Trial in Progress: SWOG S2210, a Phase 2 Study of Neoadjuvant Carboplatin for Localized High-risk Prostate Cancer with Germline BRCA1/2 Mutations. Eur Urol Focus. 2026 Jan; 12(1):16-18.
    View in: PubMed
    Score: 0.060
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.